ArticleFrontiers in pharmacology2026
Comparative effectiveness of CDK4/6 inhibitor plus endocrine therapy combinations in HR-positive, HER2-negative metastatic breast cancer: the inspiration 01 study.
Yan Jia et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.